Delivery Order SPE2DB22D9247-SPE2DB25FS2GL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,251.40 to DMS Pharmaceutical Group Inc. for BOTOX 100 unit vials on August 13, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected as the awardee based on its established...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The contract, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery from its Illinois location. This...
- The Defense Logistics Agency awarded a $2,587.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Botox 200 Unit Vials, with an ultimate completion date of September 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,940.55 to DMS Pharmaceutical Group Inc. for Botox 200-unit vials. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a pharmaceutical supply requirement fulfilled through DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $19,405.50 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The product will be delivered to Park Ridge, Illinois and will support pharmaceutical supply needs within the federal...
- The Defense Logistics Agency awarded a $9,702.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 10, 2025, for 200-unit vials of Botox, with an ultimate completion date of October 1, 2025. The award was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facilities in Park Ridge. This delivery order represents a relatively modest...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 unit vials. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its location in Park Ridge, IL. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,312.85 to DMS Pharmaceutical Group Inc. for the supply of Botox 100 unit vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order carries an ultimate completion date of September 24, 2025, and represents a specific fulfillment under the company's broader procurement...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $97,027.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This award represents a discrete fulfillment order issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,174.80 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 Unit Vials. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 30, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted...
- SPE2DB22D9247Indefinite Delivery Contract
- SPE2DB22D9247-SPE2DB25FS2GLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,702.75 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on September 11, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a pharmaceutical supply fulfillment issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as a woman-owned small business pharmaceutical wholesaler. The contractor, based in Park Ridge, Illinois, will perform the delivery at that same location. DMS Pharmaceutical Group functions as a critical supplier within the federal pharmaceutical supply chain, specializing in the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. The company's extensive contract portfolio with DLA demonstrates its established capability to deliver specialized pharmaceutical products, including injectables such as Botox, across military health systems. This delivery order aligns with DLA's mission to provide comprehensive medical supply support to defense healthcare operations and underscores DMS Pharmaceutical Group's role as a preferred vendor for pharmaceutical procurement across federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/11/25 |